These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12151907)

  • 1. Weight and blood pressure change during clozapine treatment.
    Baymiller SP; Ball P; McMahon RP; Buchanan RW
    Clin Neuropharmacol; 2002; 25(4):202-6. PubMed ID: 12151907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment.
    Baymiller SP; Ball P; McMahon RP; Buchanan RW
    Schizophr Res; 2003 Jan; 59(1):49-57. PubMed ID: 12413642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol.
    Krakowski M; Czobor P; Citrome L
    Schizophr Res; 2009 May; 110(1-3):95-102. PubMed ID: 19269139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.
    Arango C; Breier A; McMahon R; Carpenter WT; Buchanan RW
    Am J Psychiatry; 2003 Aug; 160(8):1421-7. PubMed ID: 12900303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of clozapine on weight: a controlled study.
    Bustillo JR; Buchanan RW; Irish D; Breier A
    Am J Psychiatry; 1996 Jun; 153(6):817-9. PubMed ID: 8633697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI; Czobor P; Nolan KA
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clozapine and haloperidol on some autonomic and psychomotor functions, and on serum prolactin concentration, in healthy subjects.
    Pretorius JL; Phillips M; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Sep; 52(3):322-6. PubMed ID: 11560566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.
    Basson BR; Kinon BJ; Taylor CC; Szymanski KA; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Apr; 62(4):231-8. PubMed ID: 11379836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia.
    Rosenheck R; Evans D; Herz L; Cramer J; Xu W; Thomas J; Henderson W; Charney D
    Schizophr Bull; 1999; 25(4):709-19. PubMed ID: 10667741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol.
    Rosenheck R; Chang S; Choe Y; Cramer J; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 May; 61(5):382-6. PubMed ID: 10847315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and hypertension: a chart review of 82 patients.
    Henderson DC; Daley TB; Kunkel L; Rodrigues-Scott M; Koul P; Hayden D
    J Clin Psychiatry; 2004 May; 65(5):686-9. PubMed ID: 15163256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight and leptin plasma levels during treatment with antipsychotic drugs.
    Kraus T; Haack M; Schuld A; Hinze-Selch D; Kühn M; Uhr M; Pollmächer T
    Am J Psychiatry; 1999 Feb; 156(2):312-4. PubMed ID: 9989571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
    J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.